Dayawansa Nalin H, Baratchi Sara, Peter Karlheinz
Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Department of Cardiology, Alfred Hospital, Melbourne, VIC, Australia.
Front Cardiovasc Med. 2022 Mar 9;9:783543. doi: 10.3389/fcvm.2022.783543. eCollection 2022.
Calcific aortic valve disease (CAVD) is a common acquired valvulopathy, which carries a high burden of mortality. Chronic inflammation has been postulated as the predominant pathophysiological process underlying CAVD. So far, no effective medical therapies exist to halt the progression of CAVD. This review aims to outline the known pathways of inflammation and calcification in CAVD, focussing on the critical roles of mechanical stress and mechanosensing in the perpetuation of valvular inflammation. Following initiation of valvular inflammation, dysregulation of proinflammatory and osteoregulatory signalling pathways stimulates endothelial-mesenchymal transition of valvular endothelial cells (VECs) and differentiation of valvular interstitial cells (VICs) into active myofibroblastic and osteoblastic phenotypes, which in turn mediate valvular extracellular matrix remodelling and calcification. Mechanosensitive signalling pathways convert mechanical forces experienced by valve leaflets and circulating cells into biochemical signals and may provide the positive feedback loop that promotes acceleration of disease progression in the advanced stages of CAVD. Mechanosensing is implicated in multiple aspects of CAVD pathophysiology. The mechanosensitive RhoA/ROCK and YAP/TAZ systems are implicated in aortic valve leaflet mineralisation in response to increased substrate stiffness. Exposure of aortic valve leaflets, endothelial cells and platelets to high shear stress results in increased expression of mediators of VIC differentiation. Upregulation of the Piezo1 mechanoreceptor has been demonstrated to promote inflammation in CAVD, which normalises following transcatheter valve replacement. Genetic variants and inhibition of Notch signalling accentuate VIC responses to altered mechanical stresses. The study of mechanosensing pathways has revealed promising insights into the mechanisms that perpetuate inflammation and calcification in CAVD. Mechanotransduction of altered mechanical stresses may provide the sought-after coupling link that drives a vicious cycle of chronic inflammation in CAVD. Mechanosensing pathways may yield promising targets for therapeutic interventions and prognostic biomarkers with the potential to improve the management of CAVD.
钙化性主动脉瓣疾病(CAVD)是一种常见的后天性瓣膜病,死亡率负担很高。慢性炎症被认为是CAVD潜在的主要病理生理过程。到目前为止,尚无有效的药物治疗方法来阻止CAVD的进展。本综述旨在概述CAVD中已知的炎症和钙化途径,重点关注机械应力和机械传感在瓣膜炎症持续存在中的关键作用。瓣膜炎症开始后,促炎和骨调节信号通路的失调会刺激瓣膜内皮细胞(VECs)的内皮-间充质转化以及瓣膜间质细胞(VICs)分化为活跃的肌成纤维细胞和成骨细胞表型,进而介导瓣膜细胞外基质重塑和钙化。机械敏感信号通路将瓣膜小叶和循环细胞所经历的机械力转化为生化信号,并可能提供促进CAVD晚期疾病进展加速的正反馈回路。机械传感与CAVD病理生理学的多个方面有关。机械敏感的RhoA/ROCK和YAP/TAZ系统与主动脉瓣小叶矿化有关,以应对底物硬度增加。主动脉瓣小叶、内皮细胞和血小板暴露于高剪切应力会导致VIC分化介质的表达增加。已证明Piezo1机械感受器的上调会促进CAVD中的炎症,经导管瓣膜置换后炎症会恢复正常。基因变异和Notch信号通路的抑制会加剧VIC对机械应力改变的反应。对机械传感途径的研究揭示了对CAVD中炎症和钙化持续存在机制的有前景的见解。改变的机械应力的机械转导可能提供寻求的耦合联系,从而驱动CAVD中慢性炎症的恶性循环。机械传感途径可能产生有前景的治疗干预靶点和预后生物标志物,有可能改善CAVD的管理。